Must-See Earnings Estimates NYSE:NUVB, NYSEAMERICAN:RVP, NYSEAMERICAN:PTN, NASDAQ:INVO

NUVATION BIO (NYSE:NUVB) EARNINGS INFORMATION (NYSE:NUVB)

Nuvation Bio last issued its earnings results on May 16th, 2021. The reported ($0.12) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.07) by $0.05. Nuvation Bio has generated $0.00 earnings per share over the last year. Nuvation Bio has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Monday, August 16th, 2021 based off prior year’s report dates.

IS NUVATION BIO A BUY RIGHT NOW? (NYSE:NUVB)

6 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for Nuvation Bio in the last twelve months. There are currently 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should “buy” Nuvation Bio stock.
Nuvation Bio

RETRACTABLE TECHNOLOGIES (NYSEAMERICAN:RVP) EARNINGS INFORMATION (NYSEAMERICAN:RVP)

Retractable Technologies last issued its earnings results on April 1st, 2021. The reported $0.35 earnings per share for the quarter. The firm earned $32 million during the quarter. Retractable Technologies has generated $0.00 earnings per share over the last year and currently has a price-to-earnings ratio of 19.1. Retractable Technologies has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Friday, August 13th, 2021 based off prior year’s report dates.

WHAT STOCKS DOES MARKETBEAT LIKE BETTER THAN RETRACTABLE TECHNOLOGIES? (NYSEAMERICAN:RVP)

Wall Street analysts have given Retractable Technologies a “N/A” rating, but there may be better buying opportunities in the stock market. Some of MarketBeat’s past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Retractable Technologies wasn’t one of them. MarketBeat thinks these five companies may be even better buys.

PALATIN TECHNOLOGIES (NYSEAMERICAN:PTN) EARNINGS INFORMATION (NYSEAMERICAN:PTN)

Palatin Technologies last announced its earnings results on May 17th, 2021. The biopharmaceutical company reported ($0.03) earnings per share for the quarter, meeting the consensus estimate of ($0.03). Palatin Technologies has generated ($0.10) earnings per share over the last year. Palatin Technologies has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Monday, September 27th, 2021 based off prior year’s report dates.

IS PALATIN TECHNOLOGIES A BUY RIGHT NOW? (NYSEAMERICAN:PTN)

1 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for Palatin Technologies in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should “buy” Palatin Technologies stock.
Palatin Technologies

INVO BIOSCIENCE (NASDAQ:INVO) EARNINGS INFORMATION (NASDAQ:INVO)

INVO Bioscience last issued its quarterly earnings results on May 16th, 2021. The reported ($0.25) EPS for the quarter, missing the consensus estimate of ($0.17) by $0.08. INVO Bioscience has generated ($0.32) earnings per share over the last year. INVO Bioscience has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Thursday, August 12th, 2021 based off prior year’s report dates.

IS INVO BIOSCIENCE A BUY RIGHT NOW? (NASDAQ:INVO)

2 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for INVO Bioscience in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should “buy” INVO Bioscience stock.
INVO Bioscience